Variability in the human immunodeficiency virus type 1 gp120 Env protein linked to phenotype-associated changes in the V3 loop

Journal of Virology

Volumn 76, Issue 8, 2002, Pages 3852-3864

  Hoffman, Noah G ^a   Seillier Moiseiwitsch, Francoise ^a   Ahn, JaeHyung ^a   Walker, Jason M ^a   Swanstrom, Ronald ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; GENETIC VARIABILITY; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; VIRUS CLASSIFICATION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; GENOTYPE; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MODELS, MOLECULAR; PEPTIDE FRAGMENTS; PHENOTYPE; PROTEIN CONFORMATION; PROTEIN STRUCTURE, QUATERNARY; STRUCTURE-ACTIVITY RELATIONSHIP; VARIATION (GENETICS);

EID: 0036196484     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.8.3852-3864.2002     Document Type: Article

References (82)

1. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1
2. A new classification for HIV-1
3. Covariability of V3 loop amino acids
4. HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 coreceptor
5. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype
6. A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism
7. Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity
8. The region of the envelope gene of human immunodeficiency virus type 1 responsible for determination of cell tropism
9. Human immunodeficiency virus type 1 tropism for T-lymphoid cell lines: Role of the V3 loop and C4 envelope determinants
10. The human immunodeficiency virus type 1 gp120 V2 domain mediates gp41-independent intersubunit contacts
11. Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates
12. Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages
13. Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4
14. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
15. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression
16. Maintenance of syncytium-inducing phenotype of HIV type 1 is associated with positively charged residues in the HIV type 1 gp120 V2 domain without fixed positions, elongation, or relocated N-linked glycosylation sites
17. Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population
18. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: Analysis by single amino acid substitution
19. Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity
20. Human immunodeficiency virus type 1 populations in blood and semen
21. Identification of a major coreceptor for primary isolates of HIV-1
22. HIV coreceptors
23. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
24. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
25. Characterization of simian-human immunodeficiency virus envelope glycoprotein epitopes recognized by neutralizing antibodies from infected monkeys
26. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
27. Simple determination of human immunodeficiency virus type 1 syncytiuminducing V3 genotype by PCR
28. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule
29. Phenotype-associated env gene variation among eight related human immunodeficiency virus type 1 clones: Evidence for in vivo recombination and determinants of cytotropism outside the V3 domain
30. Relation of phenotype evolution of HIV-1 to envelope V2 configuration
31. HIV type 1 envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors
32. Investigation of population diversity of human immunodeficiency virus type 1 in vivo by nucleotide sequencing and length polymorphism analysis of the V1/V2 hypervariable region of env
33. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1
34. Length variation of glycoprotein 120 V2 region in relation to biological phenotypes and coreceptor usage of primary HIV type 1 isolates
35. Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization
36. Small amino acid sequence changes within the V2 domain can affect the function of a T-cell line-tropic human immunodeficiency virus type 1 envelope gp120
37. + cell depletion and progression to AIDS
38. Covariation of mutations in the V3 loop of human immunodeficiency virus type 1 envelope protein: An information theoretic analysis
39. Assembly of asparagine-linked oligosaccharides
40. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
41. Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus
42. Tempo and mode of nucleotide substitutions in gag and env gene fragments in human immunodeficiency virus type 1 populations with a known transmission history
43. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells
44. Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains
45. V3 loop of the human immunodeficiency virus type 1 Env protein: Interpreting sequence variability
46. Patterns of amino acid variability in NSI-like and SI-like V3 sequences and a linked change in the CD4-binding domain of the HIV-1 Env protein
47. Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies
48. Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: Probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop
49. Evidence for the cooperation of gp120 amino acids 322 and 448 in SIVmac entry
50. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain
51. Functional characterization of the V1V2 region of human immunodeficiency virus type 1
52. Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks
53. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression
54. Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120
55. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding
56. Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection
57. The ability of HIV type 1 to use CCR-3 as a coreceptor is controlled by envelope V1/V2 sequences acting in conjunction with a CCR-5 tropic V3 loop
58. RASMOL: Biomolecular graphics for all
59. Envelope V2 configuration and HIV-1 phenotype: Clarification
60. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population
61. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection
62. A mathematical theory of communication
63. Determinants of syncytium formation in microglia by human immunodeficiency virus type 1: Role of the V1/V2 domains
64. Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1
65. In vivo sequence variability of human immunodeficiency virus type 1 envelope gp120: Association of V2 extension with slow disease progression
66. Patterns of chemokine receptor fusion cofactor utilization by human immunodeficiency virus type 1 variants from the lungs and blood
67. Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop
68. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS
69. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: Frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex
70. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
71. CD4-dependent, antibody-sensitive interactions between HIV-1 and its coreceptor CCR-5
72. Identification of the envelope V3 loop as a determinant of a CD4-negative neuronal cell tropism for HIV-1
73. Sequence diversity of V1 and V2 domains of gp120 from human immunodeficiency virus type 1: Lack of correlation with viral phenotype
74. Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes
75. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
76. Relationship of the human immunodeficiency virus type 1 gp120 third variable loop to a component of the CD4 binding site in the fourth conserved region
77. CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: Delineation of consensus motif in the V3 domain that predicts CCR-5 usage
78. Reevaluation of amino acid variability of the human immunodeficiency virus type 1 gp120 envelope glycoprotein and prediction of new discontinuous epitopes
79. Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro
80. Genotypic and phenotypic characterization of HIV-1 patients with primary infection